Sustainability positively impacts the environment, fosters transparency, and drives innovation. It is with this in mind that QUINTA-ANALYTICA are proud to announce being awarded the coveted EcoVadis Bronze medal.

EcoVadis is the world’s most trusted provider of business sustainability ratings, intelligence and collaborative performance improvement tools for global supply chains, and their sustainability scorecard ranked Quinta amongst the top companies assessed.

Providing detailed insight into environmental, social, and ethical risks, and enabling alignment to global best practices, the award recognized the continuous improvement and dedication to sustainability shown within Quinta’s business.

Upon receipt of the accolade, CCO Jiri Raska commented “as industry standards, international regulations and customer expectations are constantly evolving, it is imperative that companies like ours participate in regular assessments to benchmark ourselves and stay at the forefront of the pharmaceutical world. This award is proof that our whole team committed in this key area.”

Learn more about our approach to business and sustainability by getting in touch with us today.

Additional News

  • 31 May 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.

  • 6 April 2023

    Transdermal Patches, Films and Topicals – Putting the Skin in the Game

    Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.

  • 23 March 2023

    A Prescription Against EU Medicine Shortages – Outsourcing Stabilities

    We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.